Evidence map›Paper›PMID 19832989›Full record

ArticleBMC microbiology2009

Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting.

Nitchakarn Noranate, Franck Prugnolle, Hélène Jouin, Adama Tall, Laurence Marrama, Cheikh Sokhna, Marie-Thérèse Ekala, Micheline Guillotte, Emmanuel Bischoff, Christiane Bouchier and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. International journal for parasitology. Parasites and wildlife · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 6 countries.

Nitchakarn NoranateInstitut Pasteur, Unité d'Immunologie Moléculaire des Parasites, CNRS URA 2581, 28 rue du Dr ROUX, 75724 Paris Cedex 15, France. noranate@gmail.com
Franck Prugnolle
Hélène Jouin
Adama Tall
Laurence Marrama
Cheikh Sokhna
Marie-Thérèse Ekala
Micheline Guillotte
Emmanuel Bischoff
Christiane Bouchier
Jintana Patarapotikul
Jun Ohashi
Jean-François Trape
Christophe Rogier
Odile Mercereau-Puijalon
Institut Pasteur · FRCentre National de la Recherche Scientifique · FRInstitut de Recherche pour le Développement · BJInstitut Pasteur de Dakar · SNAgropolis International · FRInstituut voor Tropische Geneeskunde · BEMahidol Oxford Tropical Medicine Research Unit · THThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGenetic evidence for diversifying selection identified the Merozoite Surface Protein1 block2 (PfMSP1 block2) as a putative target of protective immunity against Plasmodium falciparum. The locus displays three family types and one recombinant type, each with multiple allelic forms differing by single nucleotide polymorphism as well as sequence, copy number and arrangement variation of three amino acid repeats. The family-specific antibody responses observed in endemic settings support immune selection operating at the family level. However, the factors contributing to the large intra-family allelic diversity remain unclear. To address this question, population allelic polymorphism and sequence variant-specific antibody responses were studied in a single Senegalese rural community where malaria transmission is intense and perennial.

resultsFamily distribution showed no significant temporal fluctuation over the 10 y period surveyed. Sequencing of 358 PCR fragments identified 126 distinct alleles, including numerous novel alleles in each family and multiple novel alleles of recombinant types. The parasite population consisted in a large number of low frequency alleles, alongside one high-frequency and three intermediate frequency alleles. Population diversity tests supported positive selection at the family level, but showed no significant departure from neutrality when considering intra-family allelic sequence diversity and all families combined. Seroprevalence, analysed using biotinylated peptides displaying numerous sequence variants, was moderate and increased with age. Reactivity profiles were individual-specific, mapped to the family-specific flanking regions and to repeat sequences shared by numerous allelic forms within a family type. Seroreactivity to K1-, Mad20- and R033 families correlated with the relative family genotype distribution within the village. Antibody specificity remained unchanged with cumulated exposure to an increasingly large number of alleles.

conclusionThe Pfmsp1 block2 locus presents a very large population sequence diversity. The lack of stable acquisition of novel antibody specificities despite exposure to novel allelic forms is reminiscent of clonal imprinting. The locus appears under antibody-mediated diversifying selection in a variable environment that maintains a balance between the various family types without selecting for sequence variant allelic forms. There is no evidence of positive selection for intra-family sequence diversity, consistent with the observed characteristics of the antibody response.

Indexed as

Selection, GeneticAdolescentAdultAllelesAnimalsAntibodies, ProtozoanChildChild, PreschoolDNA, ProtozoanFollow-Up StudiesGene FrequencyGenetics, PopulationGenotypeHumansInfantMalaria, FalciparumAntibodies, ProtozoanDNA, ProtozoanMerozoite Surface Protein 1

Identifiers

PMID19832989
PMCPMC2770483
OpenAlexW2004614138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.